Gene: MBLAC1
Official Full Name: metallo-beta-lactamase domain containing 1provided by HGNC
Gene Summary: Enables RNA endonuclease activity and metal ion binding activity. Involved in histone mRNA metabolic process; mRNA 3'-end processing; and positive regulation of G1/S transition of mitotic cell cycle. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21103 | MBLAC1 Knockout cell line (HeLa) | Human | MBLAC1 | 1:3~1:6 | Negative | Online Inquiry |
KO21104 | MBLAC1 Knockout cell line (HCT 116) | Human | MBLAC1 | 1:2~1:4 | Negative | Online Inquiry |
KO21105 | MBLAC1 Knockout cell line (HEK293) | Human | MBLAC1 | 1:3~1:6 | Negative | Online Inquiry |
KO21106 | MBLAC1 Knockout cell line (A549) | Human | MBLAC1 | 1:3~1:4 | Negative | Online Inquiry |
MBLAC1 Gene Knockout Cell Lines are genetically modified cellular systems that specifically lack the MBLAC1 gene, known for its involvement in the regulation of various cellular processes. These knockout cell lines serve as invaluable tools for researchers aiming to dissect the functional roles of the MBLAC1 gene in diverse biological contexts. By providing a platform devoid of the MBLAC1 protein's influence, scientists can investigate the gene's contribution to mechanisms such as cell signaling, apoptosis, and metabolic regulation.
The key function of MBLAC1 gene knockout cell lines lies in their ability to facilitate the study of gene function through loss-of-function analysis. Utilizing advanced CRISPR/Cas9 technology, these cell lines exhibit complete knockout of the MBLAC1 gene, enabling a thorough examination of downstream effects and compensatory pathways that may emerge due to its absence. Such detailed insights are critical for elucidating the gene's role in normal physiology and its potential implications in various diseases.
Scientifically, MBLAC1 gene knockout cell lines have broad applications in both basic research and clinical settings. They can be used to model common disease states, explore drug responses, and develop therapeutic strategies targeting MBLAC1-associated pathways. This capability enhances our understanding of conditions like cancer and metabolic disorders, where MBLAC1 dysregulation is implicated.
Compared to existing alternatives, like wild-type cell lines or less specific knockdown models, the MBLAC1 gene knockout cell lines offer specificity and robustness. They allow for clearer interpretation of data related to the MBLAC1 gene without the confounding effects from residual gene expression. This clarity greatly benefits the reproducibility of research findings.
For researchers and clinicians seeking to explore the intricate biology surrounding the MBLAC1 gene, these knockout cell lines offer unparalleled research precision and insight. Our company prides itself on its commitment to providing high-quality, genetically engineered models that empower the scientific community. We leverage our expertise in genetic engineering and cell line development to deliver advanced tools that foster innovative research and therapeutic advancements.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.